Press release
Fluxion Therapeutics Appoints Vince Groppi, Ph.D., to Scientific Advisory Board
San Diego, CA, USA - January 12, 2026 - Fluxion Therapeutics, a Physiomics Trademark company, today announced the appointment of Vince Groppi, Ph.D., to its Scientific Advisory Board.Image: https://www.globalnewslines.com/uploads/2026/01/de3b06a2ea4c13e09455e29926ba7f64.jpg
Dr. Vince Groppi brings over three decades of leadership in neuroscience drug discovery, specialized assay development, and translational biomarkers to Fluxion.
Dr. Groppi's career is defined by foundational contributions to ion channel screening. He was a co-inventor of the FLIPR platform, the industry standard for high-throughput screening (HTS) of ion channels and GPCRs. As CSO at Essen Bioscience, he pioneered planar patch-clamp technology and led the development of IonWorks Trademark HT, the first commercial automated patch-clamp (APC) platform.
Dr. Groppi will provide strategic scientific leadership as the company scales its ScorpION(c) ion channel analytics platform. ScorpION utilizes AI-driven interpretation to streamline complex electrophysiological data, conforming analytics to evolving regulatory requirements for cardiac safety and pro-arrhythmic risk assessment.
"Vince's expertise in bridging the gap between hardware engineering and drug discovery is unmatched," said Eli Black, CEO of Fluxion Therapeutics. "His guidance will be instrumental as we deploy ScorpION(c) to address the 'interpretation bottleneck' in cardiac safety and neuropsychiatric drug development."
"While APC has revolutionized data acquisition, the complexity of data analysis remains a significant barrier to broad adoption in safety pharmacology," said Dr. Groppi. "Fluxion's ScorpION(c) platform addresses this by applying AI to the interpretative layer of APC. I look forward to helping the team deliver these advanced analytics to the global discovery community."
About Fluxion
Fluxion Therapeutics is a U.S.-based leader in AI-driven pre-clinical assay development and screening workflows. The company specializes in omics-scale ion channel data QC and standards, XAI, developing Physiomics Trademark as the missing "fifth Big Omics", and AI integration across trans-omics network analysis and systems biology.
Media Contact
Company Name: Fluxion Therapeutics Inc
Contact Person: Ron Demuth
Email: Send Email [http://www.universalpressrelease.com/?pr=fluxion-therapeutics-appoints-vince-groppi-phd-to-scientific-advisory-board]
Phone: 858-717-2699
Country: United States
Website: https://www.fluxiontherapeutics.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fluxion Therapeutics Appoints Vince Groppi, Ph.D., to Scientific Advisory Board here
News-ID: 4345340 • Views: …
More Releases from Getnews
What is selenium yeast, and what are its benefits?
Image: https://www.globalnewslines.com/uploads/2026/01/1768205224.jpg
Selenium yeast provides benefits to the body that make it an important health care aid. This natural product is an ingredient that is usually combined with others to form part of supplements for the improvement of the organism, health, and beauty care.
The following content provides information about selenium yeast and its potential benefits.
What is selenium yeast, and its benefits?
Selenium yeast is a type of yeast, usually Saccharomyces cerevisiae, which…
Goodwin Made Releases New Original Single Titled "Pick Yourself Up"
Image: https://www.globalnewslines.com/uploads/2026/01/1768205155.jpg
Deeply personal and inspirational song was written and produced by Ken Goodwin and features powerful lead vocals by Jaime Arin
LOS ANGELES - January 12, 2026 - Goodwin Made today announced the release of a new original single titled "Pick Yourself Up [https://distrokid.com/hyperfollow/goodwinmade/pick-yourself-up-feat-jaime-arin]." Written and produced by Ken Goodwin, the deeply personal and inspirational song features lead vocals by Jaime Arin. "Pick Yourself Up" is a track that speaks directly…
Lgenie attends CES 2026: Redefining AI Hardware with an "Industrial-Grade Intell …
At CES 2026, Lgenie officially launched its innovative industrial-grade intelligent agent production line, aiming to redefine industry standards for scalable AI development. To comprehensively demonstrate the platform's capabilities, the company presented an advanced robotic dog capable of fluidly executing dance movements, engaging in natural conversation, and controlling smart home systems. Lgenie emphasized that the core value of this demonstration lies not only in the robot itself but more importantly in…
BagzDepot Announces Strategic Expansion of Wholesale Access to Custom and Blank …
Garden Grove, CA - January 12, 2026 - BagzDepot [http://www.bagzdepot.com/], a U.S.-based wholesale supplier of promotional merchandise, announced an expansion of its market positioning as a provider of wholesale and custom bags, apparel, and headwear for businesses, organizations, and events. The announcement reflects the company's focus on increasing access to bulk promotional products at wholesale pricing while supporting both customized and blank merchandise needs across multiple sectors.
Image: https://www.globalnewslines.com/uploads/2026/01/3b12327c4afde5a88c7c92ff96b2a5eb.jpg
The update represents…
More Releases for Fluxion
Single Cell Analysis Market Generated Opportunities, Future Scope 2025-2032 | 10 …
Coherent Market Insights' newly released report, Single Cell Analysis Market 2025, reveals promising growth trends in regional and global markets for the forecast period 2025-2032. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the report highlights effective strategies and opportunities within…
Single Cell Analysis Market Projected To Witness Massive Growth, 2025-2032 | Agi …
The Global Single Cell Analysis Market is expected to grow at 6.4% CAGR from 2025 to 2032.
The Latest detailed study on the global Single Cell Analysis Market 2025-2032, Outlook is performed by determining industry drivers, dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. The Single Cell Analysis Market report has…
Circulating Tumor Cells Market Predicted to Reach $26.61 Billion by 2031 | Therm …
The Global Circulating Tumor Cells Market reached US$ 11.80 billion in 2023 and is expected to reach US$ 26.61 billion by 2031, growing at a CAGR of 11.1% during the forecast period 2024-2031.
The Circulating Tumor Cells market report provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead…
Circulating Tumor Cells market to set phenomenal growth in key Regions with Top …
A latest study released by HTF MI on Global Circulating Tumor Cells Market covering key business segments and wide scope geographies to get deep dive analysed market data. The study is a perfect balance bridging both qualitative and quantitative information of Circulating Tumor Cells market. The study provides historical data (i.e. Volume** & Value) from 2013 to 2018 and forecasted till 2025*. Some are the key & emerging players that…
Global Circulating Tumor Cells Market Size, Status and Forecast 2022 : ApoCell, …
Qyresearchreports include new market research report "Global Circulating Tumor Cells Market Size, Status and Forecast 2022" to its huge collection of research reports.
The research report is an idiosyncratic presentation of the diverse segments of the global Circulating Tumor Cells market and the statistics pertaining to the current and historical path of the market’s growth. The chief idea of the market intelligence study is to provide its readers with a presentable…
Fluxion Biosciences Inc - Product Pipeline - Global Industry Analysis, Size, Gro …
Fluxion Biosciences Inc is a provider of analytical and live cell analysis tools. “Fluxion Biosciences Inc Product Pipeline” companys products include IsoFlux system and CTC kits, BioFlux System, IonFlux System, Cytation CTC imager and enumeration kits, and sequencing kits. It provides analytical services for a range of circulating tumor cell and liquid biopsy applications. Fluxion's sequencing assays solutions provide ultra-sensitivity mutation detection from CTCs and cell-free DNA.
Request For Free…
